ClinicalTrials.govpublic full text
Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
columnar cell variant thyroid gland papillary carcinoma, follicular variant thyroid gland papillary carcinoma, metastatic thyroid gland follicular carcinoma, metastatic thyroid gland papillary carcinoma, poorly differentiated thyroid gland carcinoma, recurrent differentiated thyroid gland carcinoma
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 67883 · SHA-256 e5bfa50054351e7a
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.